Ticker
FBIOCompany Name
FORTRESS BIOTECH INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -80.09M | -135.06% | $ 59.3M |
3/31/2025 | $ -74.37M | -128.7% | $ 57.78M |
12/31/2024 | $ -80.19M | -139.04% | $ 57.67M |
9/30/2024 | $ -102.22M | -163.55% | $ 62.5M |
6/30/2024 | $ -98.94M | -119.75% | $ 82.62M |
3/31/2024 | $ -110.39M | -129.7% | $ 85.11M |
12/31/2023 | $ -128.22M | -151.72% | $ 84.51M |
9/30/2023 | $ -141.13M | -174.3% | $ 80.97M |
6/30/2023 | $ -167.63M | -267.15% | $ 62.75M |
3/31/2023 | $ -175.76M | -273.57% | $ 64.25M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for FORTRESS BIOTECH INC is calculated as follows: CF - Operations [ $ -88.25M ] / Revenues [ $ 42.98M ]
(=) OCF % [ -205.32% ]
Minimum
Mar 31, 2023
Maximum
Jun 30, 2024
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 77.08% |
average | 14.31% |
median | 12.65% |
std | 21.13% |